[1] | Aartsma-Rus A, Ginjaar IB, Bushby K. The importance of genetic diagnosis for Duchenne muscular dystrophy. J Med Genet, 2016, 53(3): 145-151. | [2] | Bermejo-Pérez MJ, Márquez-Calderón S, Llanos-Méndez A. Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: a systematic review. Int J Cancer, 2007, 121(2): 225-231. | [3] | Padgett RA. New connections between splicing and human disease. Trends Genet, 2012, 28(4): 147-154. | [4] | Ars E, Serra E, García J, Kruyer H, Gaona A, Lázaro C, Estivill X. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet, 2000, 9(2): 237-247. | [5] | Soukarieh O, Gaildrat P, Hamieh M, Drouet A, Baert-Desurmont S, Frébourg T, Tosi M, Martins A. Exonic splicing mutations are more prevalent than currently estimated and can be predicted by using in silico tools. PLoS Genet, 2016, 12(1): e1005756. | [6] | Daguenet E, Dujardin G, Valcárcel J. The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches. EMBO Rep, 2015, 16(12): 1640-1655. | [7] | Singh RK, Cooper TA. Pre-mRNA splicing in disease and therapeutics. Trends Mol Med, 2012, 18(8): 472-482. | [8] | Kornblihtt AR, Schor IE, Alló M, Dujardin G, Petrillo E, Mu?oz MJ. Alternative splicing: a pivotal step between eukaryotic transcription and translation. Nat Rev Mol Cell Biol, 2013, 14(3): 153-165. | [9] | Svenson IK, Ashley-Koch AE, Gaskell PC, Riney TJ, Cumming WJK, Kingston HM, Hogan EL, Boustany RMN, Vance JM, Nance MA, Pericak-Vance MA, Marchuk DA. Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. Am J Hum Genet, 2001, 68(5): 1077-1085. | [10] | Teraoka SN, Telatar M, Becker-Catania S, Liang T, ?nengüt S, Tolun A, Chessa L, Sanal ?, Bernatowska E, Gatti RA, Concannon P. Splicing defects in the ataxia-telangiectasia gene,ATM: underlying mutations and consequences. Am J Hum Genet, 1999, 64(6): 1617-1631. | [11] | Mazoyer S, Puget N, Perrin-Vidoz L, Lynch HT, Serova-Sinilnikova OM, Lenoir GM. A BRCA1 nonsense mutation causes exon skipping. Am J Hum Genet, 1998, 62(3): 713-715. | [12] | Liu HX, Cartegni L, Zhang MQ, Krainer AR. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet, 2001, 27(1): 55-58. | [13] | Messiaen L, Callens T, De Paepe A, Craen M, Mortier G. Characterisation of two different nonsense mutations, C6792A and C6792G, causing skipping of exon 37 in the NF1 gene. Hum Genet, 1997, 101(1): 75-80. | [14] | Hartmann L, Theiss S, Niederacher D, Schaal H. Diagnostics of pathogenic splicing mutations: does bioinformatics cover all bases? Front Biosci, 2008, 13: 3252-3272. | [15] | Caminsky N, Mucaki EJ, Rogan PK. Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis. F1000Res, 2014, 3: 282. | [16] | Bloethner S, Mould A, Stark M, Hayward NK. Identification of ARHGEF17, DENND2D, FGFR3, and RB1 mutations in melanoma by inhibition of nonsense-mediated mRNA decay. Genes Chromosomes Cancer, 2008, 47(12): 1076-1085. | [17] | Denson J, Xi ZY, Wu YC, Yang WJ, Neale G, Zhang J. Screening for inter-individual splicing differences in human GSTM4 and the discovery of a single nucleotide substitution related to the tandem skipping of two exons. Gene, 2006, 379: 148-155. | [18] | Hicks MJ, Lam BJ, Hertel KJ. Analyzing mechanisms of alternative pre-mRNA splicing using in vitro splicing assays. Methods, 2005, 37(4): 306-313. | [19] | Treisman R, Orkin SH, Maniatis T. Specific transcription and RNA splicing defects in five cloned β-thalassaemia genes. Nature, 1983, 302(5909): 591-596. | [20] | Wieringa B, Meyer F, Reiser J, Weissmann C. Unusual splice sites revealed by mutagenic inactivation of an authentic splice site of the rabbit β-globin gene. Nature, 1983, 301(5895): 38-43. | [21] | Kishore S, Khanna A, Stamm S. Rapid generation of splicing reporters with pSpliceExpress. Gene, 2008, 427(1-2): 104-110. | [22] | Cooper TA. Use of minigene systems to dissect alternative splicing elements. Methods, 2005, 37(4): 331-340. | [23] | Anczuków O, Buisson M, Salles MJ, Triboulet S, Longy M, Lidereau R, Sinilnikova OM, Mazoyer S. Unclassified variants identified in BRCA1 exon 11: Consequences on splicing. Genes Chromosomes Cancer, 2008, 47(5): 418-426. | [24] | Di Giacomo D, Gaildrat P, Abuli A, Abdat J, Frébourg T, Tosi M, Martins A. Functional analysis of a large set of BRCA2 exon 7 variants highlights the predictive value of hexamer scores in detecting alterations of exonic splicing regulatory elements. Hum Mutat, 2013, 34(11): 1547-1557. | [25] | Naryshkin NA, Weetall M, Dakka A, Narasimhan J, Zhao X, Feng ZH, Ling KKY, Karp GM, Qi HY, Woll MG, Chen GM, Zhang NJ, Gabbeta V, Vazirani P, Bhattacharyya A, Furia B, Risher N, Sheedy J, Kong R, Ma JY, Turpoff A, Lee CS, Zhang XY, Moon YC, Trifillis P, Welch EM, Colacino JM, Babiak J, Almstead NG, Peltz SW, Eng LA, Chen KS, Mull JL, Lynes MS, Rubin LL, Fontoura P, Santarelli L, Haehnke D, McCarthy KD, Schmucki R, Ebeling M, Sivaramakrishnan M, Ko CP, Paushkin SV, Ratni H, Gerlach I, Ghosh A, Metzger F. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy. Science, 2014, 345(6197): 688-693. | [26] | Divina P, Kvitkovicova A, Buratti E, Vorechovsky I. Ab initio prediction of mutation-induced cryptic splice-site activation and exon skipping. Eur J Hum Genet, 2009, 17(6): 759-765. | [27] | Schwartz S, Hall E, Ast G. SROOGLE: webserver for integrative, user-friendly visualization of splicing signals. Nucleic Acids Res, 2009, 37: W189-W192. | [28] | Faber K, Glatting KH, Mueller PJ, Risch A, Hotz- Wagenblatt A. Genome-wide prediction of splice-modifying SNPs in human genes using a new analysis pipeline called AASsites. BMC Bioinformatics, 2011, 12 Suppl 4: S2. | [29] | Houdayer C, Caux-Moncoutier V, Krieger S, Barrois M, Bonnet F, Bourdon V, Bronner M, Buisson M, Coulet F, Gaildrat P, Lefol C, Léone M, Mazoyer S, Muller D, Remenieras A, Révillion F, Rouleau E, Sokolowska J, Vert JP, Lidereau R, Soubrier F, Sobol H, Sevenet N, Bressac-de Paillerets B, Hardouin A, Tosi M, Sinilnikova OM, Stoppa-Lyonnet D. Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants. Hum Mutat, 2012, 33(8): 1228-1238. | [30] | Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet, 2002, 3(4): 285-298. | [31] | Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res, 2003, 31(13): 3568-3571. | [32] | Cartegni L, Hastings ML, Calarco JA, de Stanchina E, Krainer AR. Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2. Am J Hum Genet, 2006, 78(1): 63-77. | [33] | Xiong HY, Alipanahi B, Lee LJ, Bretschneider H, Merico D, Yuen RKC, Hua YM, Gueroussov S, Najafabadi HS, Hughes TR, Morris Q, Barash Y, Krainer AR, Jojic N, Scherer SW, Blencowe BJ, Frey BJ. The human splicing code reveals new insights into the genetic determinants of disease. Science, 2015, 347(6218): 1254806. | [34] | Erkelenz S, Theiss S, Otte M, Widera M, Peter JO, Schaal H. Genomic HEXploring allows landscaping of novel potential splicing regulatory elements. Nucleic Acids Res, 2014, 42(16): 10681-10697. | [35] | Fairbrother WG, Yeh RF, Sharp PA, Burge CB. Predictive identification of exonic splicing enhancers in human genes. Science, 2002, 297(5583): 1007-1013. | [36] | Li YI, van de Geijn B, Raj A, Knowles DA, Petti AA, Golan D, Gilad Y, Pritchard JK. RNA splicing is a primary link between genetic variation and disease. Science, 2016, 352(6285): 600-604. |
|